120 related articles for article (PubMed ID: 27190351)
1. Midkine, a heparin-binding growth factor, and its roles in atherogenesis and inflammatory kidney diseases.
Şalaru DL; Arsenescu-Georgescu C; Chatzikyrkou C; Karagiannis J; Fischer A; Mertens PR
Nephrol Dial Transplant; 2016 Nov; 31(11):1781-1787. PubMed ID: 27190351
[TBL] [Abstract][Full Text] [Related]
2. Midkine in nephrogenesis, hypertension and kidney diseases.
Sato W; Sato Y
Br J Pharmacol; 2014 Feb; 171(4):879-87. PubMed ID: 24106831
[TBL] [Abstract][Full Text] [Related]
3. Midkine: A multifaceted driver of atherosclerosis.
Zhang ZZ; Wang G; Yin SH; Yu XH
Clin Chim Acta; 2021 Oct; 521():251-257. PubMed ID: 34331952
[TBL] [Abstract][Full Text] [Related]
4. Lessons from the heart and ischemic limbs: midkine as anti-inflammatory mediator for kidney diseases?
Şalaru DL; Mertens PR
Int Urol Nephrol; 2013 Jun; 45(3):893-7. PubMed ID: 23208536
[TBL] [Abstract][Full Text] [Related]
5. Midkine and the kidney: health and diseases.
Kosugi T; Sato W
Nephrol Dial Transplant; 2012 Jan; 27(1):16-21. PubMed ID: 22167595
[TBL] [Abstract][Full Text] [Related]
6. Serum levels for midkine, a heparin-binding growth factor, inversely correlate with angiotensin and endothelin receptor autoantibody titers in patients with macroangiopathy.
Salaru DL; Albert C; Königsmark U; Brandt S; Halloul Z; Heller A; Heidecke H; Dragun D; Mertens PR
Int Angiol; 2014 Aug; 33(4):372-8. PubMed ID: 25056169
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of midkine in cardiovascular disease.
Kadomatsu K; Bencsik P; Görbe A; Csonka C; Sakamoto K; Kishida S; Ferdinandy P
Br J Pharmacol; 2014 Feb; 171(4):936-44. PubMed ID: 24286213
[TBL] [Abstract][Full Text] [Related]
8. Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion.
Sato W; Takei Y; Yuzawa Y; Matsuo S; Kadomatsu K; Muramatsu T
Kidney Int; 2005 Apr; 67(4):1330-9. PubMed ID: 15780085
[TBL] [Abstract][Full Text] [Related]
9. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.
Narita H; Chen S; Komori K; Kadomatsu K
J Vasc Surg; 2008 Jun; 47(6):1322-9. PubMed ID: 18353604
[TBL] [Abstract][Full Text] [Related]
10. Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease.
Honda Y; Shishido T; Takahashi T; Watanabe T; Netsu S; Kinoshita D; Narumi T; Kadowaki S; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Kishida S; Kadomatsu K; Takeishi Y; Kubota I
Hypertension; 2016 May; 67(5):857-65. PubMed ID: 26975703
[TBL] [Abstract][Full Text] [Related]
11. Midkine proteins in cardio-vascular disease. Where do we come from and where are we heading to?
Bădilă E; Daraban AM; Ţintea E; Bartoş D; Alexandru N; Georgescu A
Eur J Pharmacol; 2015 Sep; 762():464-71. PubMed ID: 26101065
[TBL] [Abstract][Full Text] [Related]
12. Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective study.
Brandt S; Fischer A; Kreutze C; Hempel D; Gorny X; Scurt FG; Şalaru DL; Bartsch P; Bernhardt A; Bode-Böger SM; Girndt M; Fiedler R; Isermann B; Lindquist JA; Mertens PR
Int Urol Nephrol; 2022 Sep; 54(9):2407-2420. PubMed ID: 35211826
[TBL] [Abstract][Full Text] [Related]
13. [Midkine in relation to development and pathological status of the nervous system].
Muramatsu T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):275-9. PubMed ID: 7584721
[TBL] [Abstract][Full Text] [Related]
14. Structure-function analysis of full-length midkine reveals novel residues important for heparin binding and zebrafish embryogenesis.
Lim J; Yao S; Graf M; Winkler C; Yang D
Biochem J; 2013 May; 451(3):407-15. PubMed ID: 23418741
[TBL] [Abstract][Full Text] [Related]
15. Midkine: an emerging target of drug development for treatment of multiple diseases.
Muramatsu T; Kadomatsu K
Br J Pharmacol; 2014 Feb; 171(4):811-3. PubMed ID: 24460672
[TBL] [Abstract][Full Text] [Related]
16. Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage.
Kawai H; Sato W; Yuzawa Y; Kosugi T; Matsuo S; Takei Y; Kadomatsu K; Muramatsu T
Am J Pathol; 2004 Nov; 165(5):1603-12. PubMed ID: 15509530
[TBL] [Abstract][Full Text] [Related]
17. Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.
Kosugi T; Yuzawa Y; Sato W; Kawai H; Matsuo S; Takei Y; Muramatsu T; Kadomatsu K
Am J Pathol; 2006 Jan; 168(1):9-19. PubMed ID: 16400005
[TBL] [Abstract][Full Text] [Related]
18. Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.
Şalaru DL; Mertens PR; Bartsch P
Int Urol Nephrol; 2013 Oct; 45(5):1483-7. PubMed ID: 23543126
[TBL] [Abstract][Full Text] [Related]
19. Serum midkine is related to NYHA class and cystatin C in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Nov; 42(9):3704-7. PubMed ID: 21094842
[TBL] [Abstract][Full Text] [Related]
20. Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma.
Huang H; Li J; Lu Y; Min L; Li D; Dai L
Int J Clin Exp Pathol; 2015; 8(8):8809-20. PubMed ID: 26464623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
